(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

EPIMMUNE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

EPIMMUNE

ST13

US500000090307703

Classe

1, 5, 35, 42, 44

Pedido

90307703

Registro

6861916

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

29

Atualização mais recente

04/10/2022

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 35, 42, 44

Data de depósito

09/11/2020

Data de registro

04/10/2022

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

04/10/2022

Última transação

04/10/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

03

Localização do titular

Daejeon, KR

Examinador

MCCAULEY, BRENDAN D

Unidade examinadora

M50

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

GemVax & KAEL Co., LTD.
S. K. (pessoa física)

Representantes

Boris Umansky LADAS & PARRY LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 35Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Peptides for industrial purpose for analyzing and detecting certain cytokinesbiomarkerstoxins for laboratory or research use; protein in raw material form for scientific or laboratory purposes; protein in raw material form for scientific and medical research; chemical additives for use in the manufacture of foodfood preservative compositionschemical substances for preserving foodstuffsfood preservatives; artificial sweeteners for beverages; biological preparations other than for medical or veterinary purposes for use in cell cultures; stem cells other than for medical or veterinary purposes; plant extract other than for medical or veterinary purposes for use in the manufacture of dietary supplements; amino acid for use in the manufacture of dietary supplements

Classe 5

Food for babies except lacteal flour for babies; lacteal flour for babies; pharmaceutical preparations for prevention and treatment of cancer; vaccines; pharmaceutical and veterinary preparations for treatment of central or peripheral nervous system related diseases; pharmaceutical and veterinary preparations for treatment of cancer or tumor disease; pharmaceutical and veterinary preparations for treatment of benign prostatic hyperplasia; preparations for use in making medicated beveragespowdered nutritional and dietary supplement drink mixesdietary supplements for human consumption; protein dietary supplements; diet capsules; dietary supplements for animals; dietary supplements; nutraceuticals for use as dietary supplements; drug delivery agents in the form of capsulespowderstabletsedible wafers that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical preparations for diagnosis of benign prostatic hyperplasia; vitamin based beverages for medical purposes; functional beverages for relieving and preventing hangoverselectrolyte drinks for medical purposes; amino acid containing beveragesbeverages for use as a nutritional supplement

Classe 35

Providing consumer information services in the field of peptide medical products; providing a web site featuring consumer information about peptides in the fields of health and nutrition; providing consumer information about dietary supplements and nutrition in relation to peptides; consumer survey services in the field of cosmetics

Classe 42

Cosmetology research; Cosmetic research; Research and development of DNA chips; Computer software development; Computer software research; Design of computer microchips

Classe 44

Dispensing of Korean pharmaceuticals; dental servicesdental consultationsdentist servicesdental hygienist servicesdental imaging services; obesity consultation services; dental assistant services in the nature of medical assistanceoral medical care services

Publicações

Histórico de despachos e eventos da marca no USPTO.

29 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/10/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

04/10/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

19/07/2022

PUBO

PUBLISHED FOR OPPOSITION

19/07/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

29/06/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

14/06/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

14/06/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

14/06/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

14/06/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

14/06/2022

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

14/06/2022

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

07/06/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

20/05/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/05/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/05/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/05/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

19/11/2021

GNRT

NON-FINAL ACTION E-MAILED

19/11/2021

CNRT

NON-FINAL ACTION WRITTEN

19/11/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/11/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/11/2021

ALIE

ASSIGNED TO LIE

28/10/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/10/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

22/04/2021

GNRT

NON-FINAL ACTION E-MAILED

22/04/2021

CNRT

NON-FINAL ACTION WRITTEN

22/04/2021

DOCK

ASSIGNED TO EXAMINER

15/04/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/01/2021

NWAP

NEW APPLICATION ENTERED

12/11/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace EPIMMUNE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.